Related Experiment Video
Updated: Jun 18, 2025
08:11
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
2.8K
Neurocardiac pathologies associated with potassium channelopathies
Veronica Singh1, David S Auerbach1
1Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York, USA.
Epilepsia
|August 1, 2024
Summary
Voltage-gated potassium channels (Kv7.x and Kv11.x) are crucial for heart and brain function. Channelopathies increase risks for sudden death, epilepsy, and cardiac issues, highlighting the need for new therapies.
Area of Science:
- Neuroscience and Cardiology
- Molecular and Cellular Biology
- Genetics and Channelopathies
Background:
- Voltage-gated potassium channels (Kv) are vital for physiological functions, including cardiac repolarization and neuronal stabilization.
- KCNQx and KCNHx genes encode Kv7.x and Kv11.x channels, critical for electrical activity in the heart and brain.
- Dysfunction in these channels (channelopathies) is linked to severe conditions like cardiac arrhythmias, sudden cardiac death (SCD), epilepsy, and sudden unexpected death in epilepsy (SUDEP).
Purpose of the Study:
- To review the expression patterns and electrical functions of KCNQx and KCNHx channels in the brain and heart.
- To discuss clinically and electrophysiologically characterized KCNQx and KCNHx variants and their associated multi-system pathologies.
- To explore the therapeutic potential of Kv7 channel modulators for intractable epilepsy and reducing risks of sudden death.
Main Methods:
- Literature review of KCNQx and KCNHx channel expression, function, and associated channelopathies.
- Analysis of clinical and electrophysiological data for characterized KCNQx and KCNHx variants.
- Examination of the role of Kv7 channel modulators as potential anti-seizure therapies.
Main Results:
- KCNQx and KCNHx channels are ubiquitously expressed, and their dysfunction significantly increases the risk of sudden death.
- Specific variants (e.g., KCNH2, KCNQ2, KCNQ3) are associated with distinct cardiac and neurological pathologies, including refractory epilepsy.
- Intractable epilepsy, affecting one-third of epilepsy patients, leads to secondary complications impacting neurodevelopment and quality of life.
Conclusions:
- KCNQx and KCNHx channelopathies contribute to serious cardiac and neurological disorders, emphasizing their critical role in human health.
- Kv7 channel modulators represent a promising therapeutic avenue for intractable epilepsy and preventing sudden death.
- Further understanding of Kv channel roles is essential for developing novel, safe, and effective treatments for at-risk individuals.
More Related Videos
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
909
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
952
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
952
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
01:19Electrophysiology of Normal Cardiac Rhythm
2.7K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
2.7K
01:26Voltage-gated Ion Channels
8.1K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.1K
01:30Cardiac Action Potential
1.2K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.2K